ACME Solar Holdings Limited (BOM:544283)

CTI BioPharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	29,160	3,089	5,474	4,785	5,038
Short-Term Investments	-	-	7,715	7,048	1,292	538.22
Accounts Receivable	-	3,808	4,240	7,092	9,422	8,987
Other Receivables	-	-	1,452	1,763	1,797	1,842
Inventory	-	39.27	-	-	-	-
Prepaid Expenses	-	-	56.5	51.52	51.57	61.53
Loans Receivable Current	-	-	403.68	323.13	357.61	1,589
Other Current Assets	-	4,810	14,597	1,829	4,071	4,777
Total Current Assets	-	37,817	31,553	23,582	21,776	22,833
Property, Plant & Equipment	-	136,761	95,793	87,782	74,499	90,811
Other Intangible Assets	-	0.26	0.28	0.3	0.32	3.16
Long-Term Investments	-	2,750	0.77	226.82	249.16	246.47
Long-Term Loans Receivable	-	1,874	1,168	3,439	1,623	-
Long-Term Deferred Tax Assets	-	2,635	1,929	2,476	1,598	1,614
Long-Term Accounts Receivable	-	-	383.36	972.34	1,048	1,917
Other Long-Term Assets	-	2,200	3,115	3,391	8,074	7,643
Total Assets	-	184,037	133,941	121,870	108,867	125,068
Accounts Payable	-	2,247	737.58	621.1	2,730	1,497
Accrued Expenses	-	11.55	1,471	1,377	1,127	1,855
Short-Term Debt	-	-	451.97	1,287	2,718	3,450
Current Portion of Long-Term Debt	-	5,655	4,750	4,294	3,409	7,949
Current Unearned Revenue	-	-	487.26	185.92	106.38	162.28
Current Portion of Leases	-	481.97	305.55	308.73	311.34	289.12
Current Income Taxes Payable	-	1.46	259.69	0.13	3.64	106.71
Other Current Liabilities	-	4,798	5,796	1,622	2,055	1,768
Total Current Liabilities	-	13,195	14,260	9,696	12,461	17,076
Long-Term Debt	-	98,572	76,964	80,993	69,509	82,264
Long-Term Leases	-	5,048	2,882	3,253	3,198	3,369
Long-Term Unearned Revenue	-	17,144	10,702	6,589	2,682	3,593
Pension & Post-Retirement Benefits	-	-	13.71	13.52	12.64	10.01
Long-Term Deferred Tax Liabilities	-	2,968	2,120	1,600	901.29	175.08
Other Long-Term Liabilities	-	2,017	1,086	420.43	11.72	5.91
Total Liabilities	-	138,944	108,028	102,565	88,776	106,493
Common Stock	-	1,210	1,044	1,044	1,044	1,044
Additional Paid-In Capital	-	-	23,020	23,020	23,020	23,020
Retained Earnings	-	-	2,836	-3,562	-3,432	-3,860
Comprehensive Income & Other	-	43,896	-986.93	-1,496	-1,545	-1,629
Total Common Equity	45,106	45,106	25,913	19,006	19,088	18,575
Minority Interest	-	-12.88	-	298.99	1,004	-
Shareholders' Equity	45,093	45,093	25,913	19,305	20,092	18,575
Total Liabilities & Equity	-	184,037	133,941	121,870	108,867	125,068
Total Debt	109,757	109,757	85,354	90,136	79,145	97,320
Net Cash (Debt)	-80,597	-80,597	-74,551	-77,613	-73,069	-91,744
Net Cash Per Share	-135.77	-144.82	-134.05	-139.55	-131.38	-164.96
Filing Date Shares Outstanding	605.69	573.78	522.21	522.21	522.21	980.98
Total Common Shares Outstanding	605.69	573.78	522.21	522.21	522.21	980.98
Working Capital	-	24,622	17,293	13,886	9,315	5,757
Book Value Per Share	78.61	78.61	49.62	36.39	36.55	18.94
Tangible Book Value	45,106	45,106	25,913	19,005	19,087	18,572
Tangible Book Value Per Share	78.61	78.61	49.62	36.39	36.55	18.93
Land	-	-	-	2,836	2,830	4,431
Buildings	-	-	-	32.01	32.01	32.01
Machinery	-	-	-	85,963	76,741	103,305
Construction In Progress	-	-	28,228	21,473	12,728	972.01

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.